US Patent:
20090137527, May 28, 2009
Inventors:
Per Gjorstrup - Cambridge MA, US
Shixin Qin - Lexington MA, US
Lijun Wu - Lexington MA, US
Assignee:
Resolvyx Pharmaceuticals, Inc. - Bedford MA
International Classification:
A61K 31/695
A61K 31/232
A61K 31/202
A61K 31/60
A61P 37/02
US Classification:
514 63, 514549, 514560, 514165
Abstract:
The invention relates to methods of modulating immune function, suppressing immune response, treating autoimmune diseases or autoimmune disorders, and treating diseases, sequelae or pathological conditions mediated by an activation of the immune system comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.